1. Home
  2. SWKH vs JYNT Comparison

SWKH vs JYNT Comparison

Compare SWKH & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWKH
  • JYNT
  • Stock Information
  • Founded
  • SWKH 1996
  • JYNT 2010
  • Country
  • SWKH United States
  • JYNT United States
  • Employees
  • SWKH N/A
  • JYNT N/A
  • Industry
  • SWKH Diversified Financial Services
  • JYNT Multi-Sector Companies
  • Sector
  • SWKH Finance
  • JYNT Miscellaneous
  • Exchange
  • SWKH Nasdaq
  • JYNT Nasdaq
  • Market Cap
  • SWKH 179.1M
  • JYNT 170.3M
  • IPO Year
  • SWKH 1999
  • JYNT 2014
  • Fundamental
  • Price
  • SWKH $14.62
  • JYNT $10.64
  • Analyst Decision
  • SWKH Strong Buy
  • JYNT Strong Buy
  • Analyst Count
  • SWKH 1
  • JYNT 3
  • Target Price
  • SWKH $18.00
  • JYNT $16.33
  • AVG Volume (30 Days)
  • SWKH 12.9K
  • JYNT 80.8K
  • Earning Date
  • SWKH 08-14-2025
  • JYNT 11-06-2025
  • Dividend Yield
  • SWKH N/A
  • JYNT N/A
  • EPS Growth
  • SWKH 55.18
  • JYNT N/A
  • EPS
  • SWKH 1.41
  • JYNT N/A
  • Revenue
  • SWKH $37,409,000.00
  • JYNT $53,449,713.00
  • Revenue This Year
  • SWKH $52.93
  • JYNT $8.06
  • Revenue Next Year
  • SWKH N/A
  • JYNT $11.18
  • P/E Ratio
  • SWKH $10.36
  • JYNT N/A
  • Revenue Growth
  • SWKH 47.31
  • JYNT 277.36
  • 52 Week Low
  • SWKH $12.00
  • JYNT $9.58
  • 52 Week High
  • SWKH $16.24
  • JYNT $13.47
  • Technical
  • Relative Strength Index (RSI)
  • SWKH 47.97
  • JYNT 44.89
  • Support Level
  • SWKH $14.38
  • JYNT $10.49
  • Resistance Level
  • SWKH $15.20
  • JYNT $10.76
  • Average True Range (ATR)
  • SWKH 0.29
  • JYNT 0.33
  • MACD
  • SWKH 0.06
  • JYNT 0.03
  • Stochastic Oscillator
  • SWKH 55.04
  • JYNT 50.00

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

Share on Social Networks: